| 序号 | 受理号 | 药品名称 | 药品类型 | 申请类型 | 注册分类 | 企业名称 | 承办日期 |
| 1 | JXHL2300226 | 米罗那非片 | 化药 | 进口 | 2.4 | AriBio Co., Ltd.  anacro (Hefei) Pharmaceutical Technology Co., Ltd.; | 2023-9-16 |
| 2 | JXHL2300225 | 米罗那非片 | 化药 | 进口 | 2.4 | AriBio Co., Ltd. anacro (Hefei) Pharmaceutical Technology Co., Ltd.; | 2023-9-16 |
| 3 | JTH2300229 | 14-羟基可待因酮 | | 进口 | 化药 | Bard Pharmaceuticals Limited;Mundipharma Medical Company Limited;萌蒂（中国）制药有限公司; | 2023-9-16 |
| 4 | JTH2300228 | 二水合盐酸纳洛酮 | | 进口 | 化药 | Bard Pharmaceuticals Limited;Mundipharma Medical Company Limited;萌蒂（中国）制药有限公司; | 2023-9-16 |
| 5 | JTH2300227 | 7,8-二脱氢纳洛酮 | | 进口 | 化药 | Bard Pharmaceuticals Limited;Mundipharma Medical Company Limited;萌蒂（中国）制药有限公司; | 2023-9-16 |
| 6 | JTH2300226 | 3-O-烯丙基纳洛酮 | | 进口 | 化药 | Bard Pharmaceuticals Limited;Mundipharma Medical Company Limited;萌蒂（中国）制药有限公司; | 2023-9-16 |
| 7 | JXHL2300224 | SAR442168 | 化药 | 进口 | 1 | Sanofi-Aventis Recherche & Développement;Sanofi (China) Investment Co., Ltd.; | 2023-9-15 |
| 8 | JYHL2300001 | 瑞加诺生注射液 | 化药 | 进口 | 5.2 | Dr. Reddy's Laboratories Limited;无; | 2023-9-14 |
| 9 | JXHS2300083 | 加奈索酮口服混悬剂 | 化药 | 进口 | 5.1 | Marinus Pharmaceuticals, Inc.;Altasciences CDMO Philadelphia, LLC.;Tenacia Biotechnology (Shanghai) Co., Ltd; | 2023-9-14 |
| 10 | JXSL2300169 | GSK1070806注射液 | 治疗用生物制品 | 进口 | 1 | GlaxoSmithKline Intellectual Property Development Limited;GlaxoSmithKline (China) Investment Co., LTD; | 2023-9-12 |
| 11 | JXHL2300223 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 12 | JXHL2300222 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 13 | JXHL2300221 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 14 | JXHL2300220 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 15 | JXHL2300219 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 16 | JXHL2300218 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 17 | JXHL2300217 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 18 | JXHL2300216 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 19 | JXHL2300215 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 20 | JXHL2300214 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 21 | JXHL2300213 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 22 | JXHL2300212 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 23 | JXHL2300211 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 24 | JXHL2300210 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-12 |
| 25 | JXSL2300168 | Talque**ab注射液 | 治疗用生物制品 | 进口 | 2.2 | Janssen Research & Development, LLC;Johnson & Johnson (China) Investment Ltd.; | 2023-9-11 |
| 26 | JXSL2300167 | Talque**ab注射液 | 治疗用生物制品 | 进口 | 2.2 | Janssen Research & Development, LLC;Johnson & Johnson (China) Investment Ltd.; | 2023-9-11 |
| 27 | JXSL2300166 | Teclis**ab 注射液 | 治疗用生物制品 | 进口 | 2.2 | Janssen Research & Development, LLC;Johnson & Johnson (China) Investment Ltd.; | 2023-9-11 |
| 28 | JXSL2300165 | Teclis**ab 注射液 | 治疗用生物制品 | 进口 | 2.2 | Janssen Research & Development, LLC;Johnson & Johnson (China) Investment Ltd.; | 2023-9-11 |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对